It Started With A Problem
Brain cancer is a complex and deadly disease; treatment decisions rely on interpreting multiple tumor characteristics and changes on MRIs throughout the care process. Dr. Aly Abayazeed, our Co-Founder, former Chief Medical Officer, and a practicing Neuroradiologist, was searching for a more insightful, empirical and consistent method to analyze brain tumor MRIs to help make the best quality treatment decisions for his patients.
Seeing no clinically-available products, the solution was to build a new platform tailored to treating teams to address these issues, and many more.
And thus began the Neosoma story...

Filter Team:

Ken Kolodziej
Co-Founder and Chief Executive Officer

Benjamin Ellingson, PhD
Scientific Advisor: R&D

Jerrold Boxerman, MD
Medical Advisor

Roger Stupp, MD
Medical Advisor

John Liedtky
Chief Strategy and Commercial Officer

Golnaz Moeini
Regulatory

Kambiz Nael, MD
Medical Advisor

Ashley Ghiaseddin, MD
Medical Advisor

Michael Hill
Chief Technology Officer

Katherine Kacena, PhD
Biostatistics

Richard Stark
Strategic Advisor

Nicklaus Khan, MD
Medical Advisor

Mauricio Reyes, PhD
AI Development

Michael Müller
AI Development

Arlen Meyers, MD MBA
Strategic Advisor